ClinicalTrials.Veeva

Menu

Plethismographic Perfusion Index in Neonates

S

Shaare Zedek Medical Center

Status

Unknown

Conditions

Persistent Pulmonary Hypertension of the Newborn
Patent Ductus Arteriosus

Treatments

Device: PPG

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Photoplethismography will be measured and compared in newborns suffering from patent ductus arteriosus and normal controls.

Full description

Newborn babies admitted to the NICU and well baby will be connected to a specially designed photoplethismograph (PPG). Right hand (pre ductal), and and one of the legs (postductal) values will be compared, based on the formula Delta amplitude of PPG / baseline absorption (perfusion index (PI)). Normal values will be defined in healthy term and preterm babies, and clinical conditions in which the PI is expected to change (Patent Ductus Artheriosus, Persistent pulmonary hypertension of the newborn)will be compared with these normal values.

Enrollment

100 estimated patients

Sex

All

Ages

Under 3 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • PDA, PPHN and Normal babies who underwent echocardiography

Exclusion criteria

  • Other cardiac diseases

Trial design

100 participants in 4 patient groups

Term
Description:
Normal Term Newborn Intervention: PPG
Treatment:
Device: PPG
Preterm
Description:
Preterm babies admitted to the NICU not suffering from the conditions to be studied Intervention: PPG
Treatment:
Device: PPG
PDA
Description:
Patent Ductus Arteriosus Intervention: PPG
Treatment:
Device: PPG
PPHN
Description:
Persistent Pulmonary Hypertension Intervention: PPG
Treatment:
Device: PPG

Trial contacts and locations

1

Loading...

Central trial contact

Ruben Bromiker, MD; Itamar Nitzan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems